Market Cap 16.32M
Revenue (ttm) 0.00
Net Income (ttm) -11.13M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 1,354,941
Avg Vol 265,514
Day's Range N/A - N/A
Shares Out 37.77M
Stochastic %K 1%
Beta 1.62
Analysts Strong Sell
Price Target $8.38

Company Profile

NeuroSense Therapeutics Ltd., a clinical-stage biotechnology company, focuses on discovering and developing treatments for patients suffering from neurodegenerative diseases in the United States and internationally. The company's lead product is PrimeC, an extended-release oral formulation of a fixed-dose combination of ciprofloxacin and celecoxib, currently under Phase 2b/3 clinical trials for the treatment of amyotrophic lateral sclerosis, and completed Phase 2 clinical trials for the treatmen...

Industry: Biotechnology
Sector: Healthcare
Phone: 972 9 799 6183
Address:
Building B, 11 HaMenofim Street, Herzliya, Israel
lev57
lev57 Aug. 19 at 5:27 PM
$NRSN No one will intimidate and break us. Together we will return the value to the society that is worth it. We cannot be broken as a group.
0 · Reply
lev57
lev57 Aug. 19 at 5:23 PM
$NRSN All the prophets of wrath are repeating "We told you so" Maybe they are part of the problem for the fall? Together we will restore the value to the society that is worth it.
0 · Reply
lev57
lev57 Aug. 19 at 5:20 PM
$NRSN This turnover is not just high. A lot of goods were bought cheaply. Together we will return the value to the company that made it worth it.
0 · Reply
tiddyy
tiddyy Aug. 19 at 5:20 PM
$NRSN To all the people. I told you. GGs
0 · Reply
lev57
lev57 Aug. 19 at 5:04 PM
$NRSN alon keep me updated. I operate in multiple channels to bring value to investors. Official updates in due course. Don't be tempted and sell cheap. Buy cheap and sell high.
0 · Reply
lev57
lev57 Aug. 19 at 4:45 PM
$NRSN I wonder who did it. Maybe the one who warned me? The short-termists came and broke up the company. Together we will prevent it from them.
0 · Reply
IntentionalTrades
IntentionalTrades Aug. 19 at 4:29 PM
$NRSN I warned the would be investors, hopefully nobody lost money.
0 · Reply
lev57
lev57 Aug. 19 at 4:27 PM
$NRSN The short-termists came to dismantle the company. Together we will prevent this from them.
0 · Reply
lev57
lev57 Aug. 19 at 3:52 PM
$NRSN Something is brewing that hasn't been announced yet. It's worth waiting. Don't sell cheap. You'll regret it.
0 · Reply
Stekli27
Stekli27 Aug. 19 at 3:48 PM
$NRSN why such a volume????
0 · Reply
Latest News on NRSN
NeuroSense Issues CEO Letter to Shareholders

Aug 13, 2026, 9:30 AM EDT - 6 days ago

NeuroSense Issues CEO Letter to Shareholders


NeuroSense Therapeutics Slides: Corporate presentation

Jul 28, 2026, 8:00 AM EDT - 22 days ago

NeuroSense Therapeutics Slides: Corporate presentation


NeuroSense Therapeutics Slides: Corporate presentation

May 4, 2026, 7:00 AM EDT - 3 months ago

NeuroSense Therapeutics Slides: Corporate presentation


NeuroSense Announces Pricing of Insider-Led PIPE Financing

Apr 28, 2026, 2:30 PM EDT - 4 months ago

NeuroSense Announces Pricing of Insider-Led PIPE Financing


NeuroSense announces departure of Chief Medical Officer

2026-04-26T22:31:45.000Z - 4 months ago

NeuroSense announces departure of Chief Medical Officer


NeuroSense Therapeutics Slides: Corporate presentation

Apr 14, 2026, 7:00 AM EDT - 4 months ago

NeuroSense Therapeutics Slides: Corporate presentation


NeuroSense granted Brazilian patent covering PrimeC composition

2026-04-06T13:34:33.000Z - 4 months ago

NeuroSense granted Brazilian patent covering PrimeC composition


NeuroSense Granted Brazilian Patent Covering PrimeC Composition

Apr 6, 2026, 9:20 AM EDT - 4 months ago

NeuroSense Granted Brazilian Patent Covering PrimeC Composition


NeuroSense Therapeutics Annual report: Q4 2025

Mar 31, 2026, 9:30 AM EDT - 5 months ago

NeuroSense Therapeutics Annual report: Q4 2025


NeuroSense Therapeutics Earnings release: Q4 2025

Mar 31, 2026, 9:30 AM EDT - 5 months ago

NeuroSense Therapeutics Earnings release: Q4 2025


PrimeC New Data to Be Presented at AD/PD™ 2026 Conference

Mar 18, 2026, 8:00 AM EDT - 5 months ago

PrimeC New Data to Be Presented at AD/PD™ 2026 Conference


NeuroSense Therapeutics Slides: Corporate presentation

Mar 11, 2026, 7:00 AM EDT - 5 months ago

NeuroSense Therapeutics Slides: Corporate presentation


NeuroSense initiated with a Buy at Roth Capital

2026-03-10T08:30:39.000Z - 5 months ago

NeuroSense initiated with a Buy at Roth Capital


NeuroSense files $150M mixed securities shelf

2026-01-29T22:30:20.000Z - 7 months ago

NeuroSense files $150M mixed securities shelf


NeuroSense Therapeutics Slides: Corporate presentation

Jan 4, 2026, 7:00 AM EST - 8 months ago

NeuroSense Therapeutics Slides: Corporate presentation


NeuroSense Therapeutics Slides: Corporate Presentation

Dec 9, 2025, 7:00 AM EST - 9 months ago

NeuroSense Therapeutics Slides: Corporate Presentation


NeuroSense Therapeutics Transcript: Status Update

Dec 8, 2025, 8:30 AM EST - 9 months ago

NeuroSense Therapeutics Transcript: Status Update


NeuroSense to Host Investor Webinar on December 8, 2025

Nov 3, 2025, 9:15 AM EST - 10 months ago

NeuroSense to Host Investor Webinar on December 8, 2025


NeuroSense files to sell 333K ordinary shares for holders

2025-10-28T20:36:43.000Z - 10 months ago

NeuroSense files to sell 333K ordinary shares for holders


NeuroSense initiated with an Outperform at Noble Capital

2025-10-14T13:35:14.000Z - 11 months ago

NeuroSense initiated with an Outperform at Noble Capital


NeuroSense Therapeutics Earnings release: Q2 2025

Jul 31, 2025, 6:00 PM EDT - 1 year ago

NeuroSense Therapeutics Earnings release: Q2 2025


NeuroSense initiated with a Buy at D. Boral Capital

2025-05-12T11:30:59.000Z - 1 year ago

NeuroSense initiated with a Buy at D. Boral Capital


NeuroSense Therapeutics Earnings release: Q4 2024

Apr 7, 2025, 4:00 PM EDT - 1 year ago

NeuroSense Therapeutics Earnings release: Q4 2024


NeuroSense Therapeutics Annual report: Q4 2024

Apr 7, 2025, 4:00 PM EDT - 1 year ago

NeuroSense Therapeutics Annual report: Q4 2024


NeuroSense regains Nasdaq compliance

2025-01-06T14:11:26.000Z - 1 year ago

NeuroSense regains Nasdaq compliance


NeuroSense Therapeutics Earnings release: Q3 2024

Dec 18, 2024, 8:00 AM EST - 1 year ago

NeuroSense Therapeutics Earnings release: Q3 2024


lev57
lev57 Aug. 19 at 5:27 PM
$NRSN No one will intimidate and break us. Together we will return the value to the society that is worth it. We cannot be broken as a group.
0 · Reply
lev57
lev57 Aug. 19 at 5:23 PM
$NRSN All the prophets of wrath are repeating "We told you so" Maybe they are part of the problem for the fall? Together we will restore the value to the society that is worth it.
0 · Reply
lev57
lev57 Aug. 19 at 5:20 PM
$NRSN This turnover is not just high. A lot of goods were bought cheaply. Together we will return the value to the company that made it worth it.
0 · Reply
tiddyy
tiddyy Aug. 19 at 5:20 PM
$NRSN To all the people. I told you. GGs
0 · Reply
lev57
lev57 Aug. 19 at 5:04 PM
$NRSN alon keep me updated. I operate in multiple channels to bring value to investors. Official updates in due course. Don't be tempted and sell cheap. Buy cheap and sell high.
0 · Reply
lev57
lev57 Aug. 19 at 4:45 PM
$NRSN I wonder who did it. Maybe the one who warned me? The short-termists came and broke up the company. Together we will prevent it from them.
0 · Reply
IntentionalTrades
IntentionalTrades Aug. 19 at 4:29 PM
$NRSN I warned the would be investors, hopefully nobody lost money.
0 · Reply
lev57
lev57 Aug. 19 at 4:27 PM
$NRSN The short-termists came to dismantle the company. Together we will prevent this from them.
0 · Reply
lev57
lev57 Aug. 19 at 3:52 PM
$NRSN Something is brewing that hasn't been announced yet. It's worth waiting. Don't sell cheap. You'll regret it.
0 · Reply
Stekli27
Stekli27 Aug. 19 at 3:48 PM
$NRSN why such a volume????
0 · Reply
Stekli27
Stekli27 Aug. 19 at 3:05 PM
0 · Reply
lev57
lev57 Aug. 19 at 3:02 PM
$NRSN The prophets of wrath have arrived. Aliyah is not suitable for them. Don't sell cheap. Repent.
0 · Reply
IntentionalTrades
IntentionalTrades Aug. 19 at 2:56 PM
$NRSN Bulls trap in the making. Caveat Emptor
0 · Reply
Jameswilson001
Jameswilson001 Aug. 18 at 9:52 PM
0 · Reply
Zoofar
Zoofar Aug. 18 at 8:29 PM
$NRSN Dead company. nice research Zero execution. run!
0 · Reply
Holla4adolla1
Holla4adolla1 Aug. 18 at 8:19 PM
$NRSN Short term, it looks bearish. Long term, highly bullish as long as there is minimal dilution.
0 · Reply
Babilon1210
Babilon1210 Aug. 18 at 8:02 PM
$NRSN Jesus
0 · Reply
lev57
lev57 Aug. 18 at 7:28 PM
$NRSN If the trading software blocks a buy order above 0.51.
0 · Reply
lev57
lev57 Aug. 18 at 6:56 PM
$NRSN I've been trying for a few days. He doesn't respond to me. I don't understand his ignoring the situation. As soon as he responds, I'll update. In the meantime, we must prevent the crash that some people are taking advantage of us. Together, we will prevent it.
2 · Reply
Cohensha
Cohensha Aug. 18 at 6:48 PM
$NRSN I fear that stock can’t recover from the massive ATM of the last months. Clearly, letter to investors didn’t bring new hope or something that we didn’t know. Somebody try to connect with Alon?
0 · Reply
lev57
lev57 Aug. 18 at 6:38 PM
$NRSN You are scaring investors with your predictions of doom. The company has scientific evidence. They have recovered from the situation.
0 · Reply
tiddyy
tiddyy Aug. 18 at 4:55 PM
$NRSN Reverse Split news imminent, retail can push the vote to No, but they will be in serious risk of delisting, will probably do a major offering before getting delisted to mess up shareholders one last time They didn’t put this vote for fun, they knew this was coming for months, and diluted you at $0.50 even, they will take every penny from you and move on with the trial Read the trail, there are no happy endings here
0 · Reply